iGMDRD49
Canonical SMILES: CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
InChI: InChI=1S/C15H18N4O5/c1-5-9(16)12(21)8-6(4-24-14(17)22)15(23-2)13-7(18-13)3-19(15)10(8)11(5)20/h6-7,13,18H,3-4,16H2,1-2H3,(H2,17,22)/t6-,7+,13+,15-/m1/s1
InChI Key: NWIBSHFKIJFRCO-WUDYKRTCSA-N
Drug Class:
Alkylating AgentsAlkylating DrugAntibiotics, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsAzirinesCardiotoxic antineoplastic agentsCross-Linking ReagentsCytotoxic Antibiotics and Related SubstancesEnzyme InhibitorsHeterocyclic CompoundsHeterocyclic Compounds, 1-RingHeterocyclic Compounds, 2-RingImmunosuppressive AgentsIndicators and ReagentsIndolequinonesIndolesLaboratory ChemicalsMitomycinsMyelosuppressive AgentsNoxaeNucleic Acid Synthesis InhibitorsP-glycoprotein/ABCB1 SubstratesQuinonesSpecialty Uses of ChemicalsToxic ActionsDrug Targets:
DNA crosslinkerDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Mitomycin
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |